| 1. |
Martin, G.R. (1981). Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma
stem cells. Proc. Natl. Acad. Sci. U.S.A. 78, 7634–7638
|
| |
| 2. |
Evans, M.J. and Kaufman, M.H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154–156
|
| |
| 3. |
Williams, R.L., Hilton, D.J., Pease, S., Willson, T.A, Stewart, C.L., Gearing, D.P., Wagner, E.F., Metcalf, D., Nicola, N.A.,
and Gough, N.M. (1988). Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells.
Nature 336, 684–687
|
| |
| 4. |
Smith, A.G., Heath, J.K., Donaldson, D.D., Wong, G.G., Moreau, J., Stahl, M., and Rogers, D. (1988). Inhibition of pluripotential
embryonic stem cell differentiation by purified polypeptides. Nature 336, 688–690
|
| |
| 5. |
Solter, D. (2006). From teratocarcinomas to embryonic stem cells and beyond: a history of embryonic stem cell research. Nat.
Rev. Genet. 7, 319–327
|
| |
| 6. |
Nagy, A. (2008). URL: www.mshri.on.ca/nagy/r1.htm retrieved on 28th February 2008
|
| |
| 7. |
Wellcome Trust Sanger Institute. (2008). URL: www.sanger.ac.uk/Software/archives/mouse-help.shtml retrieved on 28th February
2008
|
| |
| 8. |
Keskintepe, L., Norris, K., Pacholczyk, G., Dederscheck, S.M., and Eroglu, A. (2007). Derivation and comparison of C57BL/6
embryonic stem cells to a widely used 129 embryonic stem cell line. Transgenic Res. 16, 751–758
|
| |
| 9. |
Blake, M.S., Johnston, K.H., Russell-Jones, G.J., and Gotschlich, E.C. (1984). A rapid, sensitive method for detection of
alkaline phosphatase-conjugated anti-antibody on Western blots. Anal. Biochem. 136, 175–179
|
| |
| 10. |
Ayral, A., Clarkson, S., Cheeseman, M., Wells, S., and Dear, T. (2006). A panel of optimized primers and positive control
DNAs for PCR detection of common biological contaminants in mouse cell lines and tissue samples. Lab Anim. 35, 31–36
|
| |
| 11. |
Udy, G.B., Parkes, B.D., and Wells, D.N. (1997). ES cell cycle rates affect gene targeting frequencies. Exp. Cell Res.231,
296–301
|
| |
| 12. |
Balbach, S.T., Jauch, A., Böhm-Steuer, B., Cavaleri, F.M., Han, Y.M., and Boiani M. (2007). Chromosome stability differs in
cloned mouse embryos and derivative ES cells. Dev. Biol. 308, 309–321
|
| |
| 13. |
Longo, L., Bygrave, A., Grosveld, F.G., and Pandolfi, P.P. (1997). The chromosome make-up of mouse embryonic stem cells is
predictive of somatic and germ cell chimaerism. Transgenic Res. 6, 321–328
|
| |
| 14. |
Liu, X., Wu, H., Loring, J., Hormuzdi, S., Disteche, C.M., Bornstein, P., and Jaenisch R. (1997). Trisomy eight in ES cells
is a common potential problem in gene targeting and interferes with germ line transmission. Dev. Dyn. 209, 85–91
|
| |
| 15. |
Hook, E.B. (1977). Exclusion of chromosomal mosaicism: Tables of 90%, 95%, and 99% confidence limits and comments on use.
Am. J. Hum. Genet. 29, 94–97
|
| |
| 16. |
Nicklas, W., and Weiss. J. (2000). Survey of embryonic stem cells for murine infective agents. Comp. Med. 50, 410–411
|
| |
| 17. |
Kyuwa, S. (1997). Replication of murine coronaviruses in mouse embryonic stem cell lines in vitro. Exp. Anim. 46, 311–313
|
| |
| 18. |
Lindsey, J., Boorman, G., Collins, M., Hsu, C.-K., Van Hoosier., Jr.,G., and Wagner, J. (1991) Infectious Diseases in Mice
and Rats. National Academy Press, Washington. DC. pp. 42–48
|
| |
| 19. |
Tucker, K.L., Wang, Y., Dausman, J., and Jaenisch, R. (1997). A transgenic mouse strain expressing four drug-selectable marker
genes. Nucleic Acids Res.25, 3745–3746
|
| |
| 20. |
O’Gorman, S., Dagenais, N.A., Qian, M., and Marchuk, Y. (1997). Protamine-Cre recombinase transgenes efficiently recombine
target sequences in the male germ line of mice, but not in embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 94, 14602–14607
|
| |